Boehringer walks away from Nxera's phase 2-ready schizophrenia program
Boehringer walks away from Nxera's phase 2-ready schizophrenia program
Body unavailable. Use the original source.
Boehringer walks away from Nxera's phase 2-ready schizophrenia program
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.